Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients
出版年份 2019 全文链接
标题
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients
作者
关键词
-
出版物
Seminars in Immunopathology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-04-26
DOI
10.1007/s00281-019-00743-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Retinol Binding Protein 4 Impairs Pancreatic Beta-Cell Function, Leading to the Development of Type 2 Diabetes
- (2018) RONG HUANG et al. DIABETES
- Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)
- (2018) AMY BRADSHAW KAISER et al. DIABETES
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- (2018) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Immunometabolism in 2017: Metabolism and the inflammasome in health and ageing
- (2017) Thomas Mandrup-Poulsen Nature Reviews Endocrinology
- What Does It “Mean”? A Review of Interpreting and Calculating Different Types of Means and Standard Deviations
- (2017) Marilyn Martinez et al. Pharmaceutics
- Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
- (2016) Peter Gæde et al. DIABETOLOGIA
- Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance
- (2016) Robin P. Choudhury et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control
- (2016) Carole A. Chrvala et al. PATIENT EDUCATION AND COUNSELING
- Plea for routinely presenting prediction intervals in meta-analysis
- (2016) Joanna IntHout et al. BMJ Open
- Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
- (2014) Campbell Howard et al. Cardiovascular Diabetology
- Pharmacokinetic and Pharmacodynamic Characteristics of Single-dose Canakinumab in Patients With Type 2 Diabetes Mellitus
- (2014) Adele Noe et al. CLINICAL THERAPEUTICS
- Targeting inflammation in the treatment of type 2 diabetes: time to start
- (2014) Marc Y. Donath NATURE REVIEWS DRUG DISCOVERY
- Salicylate (Salsalate) in Patients With Type 2 Diabetes
- (2013) Allison B. Goldfine ANNALS OF INTERNAL MEDICINE
- Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial
- (2013) J. Hensen et al. DIABETES & METABOLISM
- Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1 Antibody, in Patients With Type 2 Diabetes
- (2013) J. Sloan-Lancaster et al. DIABETES CARE
- Interleukin-1 antagonists for diabetes
- (2013) Thomas Mandrup-Poulsen EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
- (2013) Steven E Kahn et al. LANCET
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
- (2012) X. Wang et al. DIABETES CARE
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Bariatric Surgery for Type 2 Diabetes Reversal: The Risks
- (2011) A. Keidar DIABETES CARE
- Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
- (2011) Xinyi Li et al. Molecular Neurodegeneration
- IAPP boosts islet macrophage IL-1 in type 2 diabetes
- (2010) Thomas Mandrup-Poulsen NATURE IMMUNOLOGY
- Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra
- (2010) Mette Koefoed et al. Clinical Proteomics
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Retinol-Binding Protein 4 in Twins: Regulatory Mechanisms and Impact of Circulating and Tissue Expression Levels on Insulin Secretion and Action
- (2008) R. Ribel-Madsen et al. DIABETES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now